MRC1 and colorectal cancer: Another study of 764 MMR gene mutation carriers previously diagnosed with colorectal cancer, estimated a 3% higher risk of CaP compared to the general population, demonstrating that carriers of MMR gene mutations with colorectal cancer are at increased risk of CaP [151].